GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Long-Term Debt

North China Pharmaceutical Co (SHSE:600812) Long-Term Debt : ¥3,623 Mil (As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is North China Pharmaceutical Co Long-Term Debt?

North China Pharmaceutical Co's Long-Term Debt for the quarter that ended in Jun. 2024 was ¥3,623 Mil.

North China Pharmaceutical Co's quarterly Long-Term Debt increased from Dec. 2023 (¥4,081 Mil) to Mar. 2024 (¥4,487 Mil) but then declined from Mar. 2024 (¥4,487 Mil) to Jun. 2024 (¥3,623 Mil).

North China Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2021 (¥3,301 Mil) to Dec. 2022 (¥2,129 Mil) but then increased from Dec. 2022 (¥2,129 Mil) to Dec. 2023 (¥4,081 Mil).

North China Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for North China Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

North China Pharmaceutical Co Long-Term Debt Chart

North China Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,144.42 4,617.84 3,300.74 2,129.07 4,080.86

North China Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,399.01 3,791.30 4,080.86 4,486.60 3,623.25

North China Pharmaceutical Co  (SHSE:600812) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

North China Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of North China Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

North China Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » North China Pharmaceutical Co Ltd (SHSE:600812) » Definitions » Long-Term Debt
Comparable Companies
SZSE:300199 SZSE:000756 SHSE:600664 SZSE:002099 SHSE:600252 SHSE:600267 SZSE:000650 SHSE:600557 SHSE:601089 SZSE:300401 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XTAE:TEVA XSWX:SDZ NBIX NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 388 Heping East Road, Shijiazhuang, Hebei, CHN, 050015
Website
http://www.ncpc.com
North China Pharmaceutical Co Ltd is engaged in the manufacture and sale of antibiotics, vitamins, and pharmaceutical products in China. The main products include antibiotics such as penicillin, vitamins, cephalosporins, streptomycin, biotechnological drugs, new preparations, and biological products.
Executives
Gao Ren Long senior management
Lian Fa Zhe Director

North China Pharmaceutical Co Headlines

No Headlines